NPQ-C6 Inhibits the BCR-ABL1-STAT5 and Induces JNK, p38-MAPK, and AKT Signaling Pathways in Human Chronic Myelogenous Leukemia Cells. This evidence concerns the gene AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive.